Has John Stelmach, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,880 in general payments to John Stelmach, MD across 199 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Stelmach, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Stelmach, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Stelmach, MD

Orthopaedic Surgery · Reading, PANPI 1619975174

Payments from drug & device makers

$6,880in general payments, 2019–2025

Across 199 payments — averaging $34.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$5K
Seapearl East, Inc$1K
Zimmer Biomet$232
Novus Surgical Consultants$130
Johnson & Johnson$128
Globus Medical$87
plus $396 from 15 others

What the payments were for

Travel & lodging$67210%
Food & beverage$4,96972%
Education$1,20017%
Other$391%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	164	$4,562
Seapearl East, Inc	2	$1,345
Zimmer Biomet	3	$232
Novus Surgical Consultants	4	$130
Johnson & Johnson(2 entities)	6	$128
Globus Medical	1	$87
Vertex	3	$72
Avanos Medical	2	$39
Baxter Healthcare	1	$39
Paratek Pharmaceuticals, Inc.	2	$37
Fidia Pharma USA Inc.	1	$25
Pacira Therapeutics, Inc.	1	$25
Orthofix Medical, Inc.	1	$24
Pacira Pharmaceuticals Incorporated	1	$23
Bioventus LLC	1	$20
Heraeus Medical, LLC.	1	$17
ERMI LLC	1	$16
Orthogenrx Inc.	1	$16
Amgen	1	$16
Protega Pharmaceutials Inc	1	$16
Zyla Life Sciences, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MAKO$1,813
TRIATHLON$305
ROSA$183

How this compares

$6,880 in reported general payments places this provider in the 60th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$377,730

Medicare patients

591

Services billed

4,677

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	24	$7,212
Oxycodone Hcl	145	$1,043
Tramadol Hcl	218	$545
Celecoxib	17	$321
Diclofenac Sodium	17	$296
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	26	$255
Meloxicam	55	$68

Paid to pharmacies, not to this prescriber.